Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Ballester, Marcos ^a   Koskas, Martin ^a   Coutant, Charles ^a   Chéreau, Elisabeth ^a   Seror, Jeremy ^a   Rouzier, Roman ^a   Daraï, Emile ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EOSIN; FLUOROURACIL; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER PATIENT; CANCER STAGING; CONTINUOUS INFUSION; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPHADENECTOMY; PREOPERATIVE EVALUATION; SENTINEL LYMPH NODE BIOPSY; ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; CLASSIFICATION; CYSTADENOCARCINOMA; ENDOMETRIUM TUMOR; LABORATORY DIAGNOSIS; LYMPH NODE; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 77956481221     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-465     Document Type: Article

References (33)

1. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 2009, 105(2):109. 10.1016/j.ijgo.2009.02.010, 19345353.
2. Mariani A, Dowdy SC, Podratz KC. New surgical staging of endometrial cancer: 20 years later. Int J Gynaecol Obstet 2009, 105(2):110-111. 10.1016/j.ijgo.2009.02.008, 19285672.
3. Petru E, Luck HJ, Stuart G, Gaffney D, Millan D, Vergote I. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol 2009, 143(2):69-74. 10.1016/j.ejogrb.2008.12.015, 19195765.
4. Mikuta JJ. International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer 1993, 71(4 Suppl):1460-1463.
5. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?. Am J Obstet Gynecol 2000, 182(6):1506-1519. 10.1067/mob.2000.107335, 10871473.
6. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009, 373(9658):125-136. 10.1016/S0140-6736(08)61766-3, 2646126, 19070889.
7. Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E. Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol 2008, 15(5):1523-1529. 10.1245/s10434-008-9841-1, 18322758.
8. Delpech Y, Coutant C, Darai E, Barranger E. Sentinel lymph node evaluation in endometrial cancer and the importance of micrometastases. Surg Oncol 2008, 17(3):237-245. 10.1016/j.suronc.2008.04.001, 18499443.
9. Niikura H, Okamoto S, Yoshinaga K, Nagase S, Takano T, Ito K, Yaegashi N. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol Oncol 2007, 105(3):683-686. 10.1016/j.ygyno.2007.01.052, 17442382.
10. Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Noguchi M, Nakanishi M, Kawai M. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 2001, 80(2):139-144. 10.1006/gyno.2000.6067, 11161851.
11. Darai E, Rouzier R, Ballester M, Barranger E, Coutant C. Sentinel lymph node biopsy in gynaecological cancers: the importance of micrometastases in cervical cancer. Surg Oncol 2008, 17(3):227-235. 10.1016/j.suronc.2008.04.002, 18504122.
12. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002, 20(17):3628-3636. 10.1200/JCO.2002.02.026, 12202663.
13. Altgassen C, Pagenstecher J, Hornung D, Diedrich K, Hornemann A. A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol 2007, 105(2):457-461. 10.1016/j.ygyno.2007.01.021, 17313975.
14. Bats AS, Clement D, Larousserie F, Le Frere-Belda MA, Pierquet-Ghazzar N, Hignette C, Lecuru F. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. J Surg Oncol 2008, 97(2):141-145. 10.1002/jso.20857, 18050286.
15. Delaloye JF, Pampallona S, Chardonnens E, Fiche M, Lehr HA, De Grandi P, Delaloye AB. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol 2007, 106(1):89-93. 10.1016/j.ygyno.2007.03.003, 17442383.
16. Delpech Y, Cortez A, Coutant C, Callard P, Uzan S, Darai E, Barranger E. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol 2007, 18(11):1799-1803. 10.1093/annonc/mdm334, 17709801.
17. Frumovitz M, Bodurka DC, Broaddus RR, Coleman RL, Sood AK, Gershenson DM, Burke TW, Levenback CF. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 2007, 104(1):100-103. 10.1016/j.ygyno.2006.07.033, 16963111.
18. Lopes LA, Nicolau SM, Baracat FF, Baracat EC, Goncalves WJ, Santos HV, Lopes RG, Lippi UG. Sentinel lymph node in endometrial cancer. Int J Gynecol Cancer 2007, 17(5):1113-1117. 10.1111/j.1525-1438.2007.00909.x, 17386045.
19. Holub Z, Jabor A, Lukac J, Kliment L. Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. Med Sci Monit 2004, 10(10):CR587-591.
20. Fersis N, Gruber I, Relakis K, Friedrich M, Becker S, Wallwiener D, Wagner U. Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. Eur J Gynaecol Oncol 2004, 25(3):339-342.
21. Niikura H, Okamura C, Utsunomiya H, Yoshinaga K, Akahira J, Ito K, Yaegashi N. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 2004, 92(2):669-674. 10.1016/j.ygyno.2003.10.039, 14766264.
22. Pelosi E, Arena V, Baudino B, Bello M, Giusti M, Gargiulo T, Palladin D, Bisi G. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun 2003, 24(9):971-975. 10.1097/00006231-200309000-00005, 12960596.
23. Marchiole P, Buenerd A, Benchaib M, Nezhat K, Dargent D, Mathevet P. Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol Oncol 2005, 97(3):727-732. 10.1016/j.ygyno.2005.01.004, 15943983.
24. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C, Mangioni C. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008, 100(23):1707-1716. 10.1093/jnci/djn397, 19033573.
25. Eltabbakh GH, Shamonki J, Mount SL. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors. Gynecol Oncol 2005, 99(2):309-312. 10.1016/j.ygyno.2005.06.010, 16005945.
26. Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, Soslow RA, Dao F, Sonoda Y, Levine DA, Brown CL, Chi DS, Barakat RR, Gemignani ML. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?. Gynecol Oncol 2009, 113(2):163-169. 10.1016/j.ygyno.2009.01.003, 19232699.
27. Altgassen C, Muller N, Hornemann A, Kavallaris A, Hornung D, Diedrich K, Jarutat T. Immunohistochemical workup of sentinel nodes in endometrial cancer improves diagnostic accuracy. Gynecol Oncol 2009, 114(2):284-287. 10.1016/j.ygyno.2009.04.020, 19447478.
28. Bernardini MQ, Murphy JK. Issues surrounding lymphadenectomy in the management of endometrial cancer. J Surg Oncol 2009, 99(4):232-241. 10.1002/jso.21200, 19072933.
29. Mariani A, Webb MJ, Keeney GL, Podratz KC. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 2001, 81(1):100-104. 10.1006/gyno.2000.6111, 11277658.
30. Frei KA, Kinkel K, Bonel HM, Lu Y, Zaloudek C, Hricak H. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging-a meta-analysis and Bayesian analysis. Radiology 2000, 216(2):444-449.
31. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987, 60(8 Suppl):2035-2041.
32. Abu-Rustum NR, Gomez JD, Alektiar KM, Soslow RA, Hensley ML, Leitao MM, Gardner GJ, Sonoda Y, Chi DS, Barakat RR. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol 2009, 115(2):236-238. 10.1016/j.ygyno.2009.07.016, 19666190.
33. Fader AN, Edwards RP, Cost M, Kanbour-Shakir A, Kelley JL, Schwartz B, Sukumvanich P, Comerci J, Sumkin J, Elishaev E, Rohan LC. Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment. Gynecol Oncol 2008, 111(1):13-17. 10.1016/j.ygyno.2008.06.009, 18684499.